FDA Approves New Animal Drug for Swine Respiratory Disease

Summary

The FDA is updating its regulations to allow the use of a new animal drug, ceftiofur crystalline free acid suspension, to treat swine respiratory disease in groups of pigs where the disease has been diagnosed. This approval is based on a supplemental new animal drug application filed by Pfizer, a division of Pharmacia & Upjohn Co.